Combinostics’ cDSI and cMRI Applications, Part of the cNeuro Platform, Receive EC-certification Under the EU’s Medical Device Regulation (MDR)

cNeuro® cDSI™ and cNeuro cMRI™ achieve EC-certification under MDR, ensuring continued delivery of services to European customers.

Continue Reading Combinostics’ cDSI and cMRI Applications, Part of the cNeuro Platform, Receive EC-certification Under the EU’s Medical Device Regulation (MDR)

AAIC 2022

Attending AAIC 2022? Stop by booth 400 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.

Continue Reading AAIC 2022

Slicing through the fog of neurodegeneration with cutting-edge tools: feedback from ASNR22

ASNR22 provided a great opportunity to discuss tools that would help neuroradiologists support their referring clinicians when diagnosing patients with symptoms of dementia. Read key takeaways from Peter Ngum, Combinostics Clinical Application Specialist, and Greg Kingston, Combinostics Chief Marketing Officer (CMO).

Continue Reading Slicing through the fog of neurodegeneration with cutting-edge tools: feedback from ASNR22

103rd German X-Ray Congress

Attending the 103rd German X-Ray Congress? Stop by booth Nord 39 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.

Continue Reading 103rd German X-Ray Congress

Preserving the mind: key takeaways from AAN 2022

AAN 2022 highlighted cutting-edge research in neurology and provided opportunities for networking within the neurology community. Read key takeaways from Peter Ngum, Combinostics Clinical Application Specialist, from advances for traumatic brain injury to the future of AI and neurology.

Continue Reading Preserving the mind: key takeaways from AAN 2022